+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Global Surgical Sutures Market Size was valued at USD 3.7 Billion in 2022. The Surgical Sutures market industry is projected to grow from USD 4.2 Billion in 2023 to USD 6.3 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.20% during the forecast period (2023 - 2032). The surge in trauma cases, the expansion of chronic disease patients being admitted to hospitals, and the attractive reimbursement situation, are the key market drivers enhancing the market growth.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Both the number of trauma cases and the number of individuals with chronic conditions being admitted to hospitals has risen. It is predicted that as more orthopedic, alimentary, ophthalmic, and other situations call for surgical suturing during surgery, there will be an increase in demand for their use. The need for surgical sutures was impacted by the rise in procedures, which also helped the market grow.
The Behavioral Risk Factor Surveillance System (BRFSS) reported 2019 data showing that the adult obesity rates in the United States exceeded 35% in nine states, 30% in 31 states, and 25% in 48 states. According to the same source, Mississippi and West Virginia had the greatest percentage of adult obesity (39.5%), while Colorado had the lowest (23%). The population is becoming more obese, which is increasing demand for bariatric surgeries. This accelerates market growth by increasing demand for extra surgical sutures for use in bariatric surgeries. A number of hospitals and ambulatory surgery centers offering specialized and cutting-edge surgical suture treatments may contribute to the market expansion during the anticipated timeframe.
The need for surgical sutures in the medical industry is increasing as more procedures are performed on patients. Developments in the healthcare industry are producing better treatment techniques, which is expected to speed up market expansion. As more and more sophisticated treatment procedures are being utilized in surgeries, particularly in nations like the United Kingdom, Germany, the United States, Canada, and Japan, there is an increasing demand for surgical sutures that are useful for both surgeons and patients.
In addition, market expansion is predicted to be stimulated by the aging population. The rise in fatal auto accidents is anticipated to lead to the industry's growth. Other crucial variables, such as increased urbanization and rising disposable income, would impede the market's rise for surgical sutures. Due to favorable reimbursement circumstances and increased healthcare infrastructure spending, the market for surgical sutures will grow more quickly. Thus, driving the Surgical Sutures market revenue.
The global Surgical Sutures market segmentation, based on Application, includes ophthalmic surgery, cardiovascular surgery, orthopedic surgery, neurological surgery, and others. Cardiovascular surgery was the market segment with the biggest revenue share in 2022. This is due to the prevalence of cardiac illnesses, the availability of sufficient specialists, attractive reimbursement regulations, and advancements in diagnostic technologies. This has led to a large increase in the number of cardiac procedures, which will increase demand for surgical sutures during the projection period.
The global Surgical Sutures market segmentation, based on Type, includes absorbable and non-absorbable. Due to its capacity to offer temporary support to wounds while they heal and can withstand normal tension, absorbable segment led the worldwide surgical sutures market in 2022. The rapidly increasing demand for absorbable sutures is another indication of their ability to spontaneously dissolve. As a result, leading market players are investing money in R&D initiatives, which are anticipated to support the development of the absorbable sector in the future.
The global Surgical Sutures market segmentation, based on Filament, includes monofilament and multifilament. The multifilament category is expected to grow at the fastest pace during the forecast timeframe. The advantages of the multifilament section, such as enhanced pliability, high tensile strength, and flexibility, account for this.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
By region, Insights into the markets in North America, Europe, Asia-Pacific, and the rest of the world are provided by the study. The North America Surgical Sutures Market dominated the global market in 2022 with 45.80% share, due to the presence of significant local players, the high cost of sutures in comparison to other nations, the favorable reimbursement environment, the expansion of government programs, and the well-developed healthcare infrastructure. The considerable revenue share of North America is also primarily attributable to the region's strong domestic economy and technical advancements. Further, In the North American area, the U.S. Surgical Sutures market had the biggest market share, while the Canada Surgical Sutures market had the quickest rate of expansion.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Download Free Sample to learn more about this report
Source: Secondary Research, Primary Research, RESEARCH LAYER Database and Analyst Review
Europe Surgical Sutures market accounted for the significant market share in 2022. This is related to the role of the aging population in the rise of chronic illnesses, which leads to operations and, in turn, increases the requirement for surgical sutures. As a result, it is projected that the local market will grow. Further, In the European region, the German Surgical Sutures market had the biggest market share, and the U.K. Surgical Sutures market had the quickest rate of growth.
The Asia Pacific Surgical Sutures market is expected to register fastest CAGR from 2023 to 2032. The government is spending more money on the healthcare system to fulfill the unmet requirements in this area and there are more senior people, who are more likely to require surgery. China, India, and Japan are a few of the significant marketplaces in the Asia Pacific region. The rise of medical tourism in countries like India, Singapore, and Malaysia is another important factor driving the industry in this sector toward exponential growth. Moreover, In the Asia-Pacific region, the Indian Surgical Sutures market had the quickest rate of growth while China's Surgical Sutures market had the greatest market share.
Leading industry companies are making significant R&D investments in order to diversify their product offerings, which will drive the Surgical Sutures market's expansion. Important market developments include new product releases, contractual agreements, mergers and acquisitions, greater investments, and collaboration with other organizations. Market participants are also engaging in a number of strategic actions to increase their global footprint. The Surgical Sutures sector needs to provide affordable products if it wants to grow and thrive in a more competitive and challenging market environment.
One of the primary business strategies employed by manufacturers in the worldwide Aerospace Foam industry to assist customers and expand the market sector is local manufacturing to reduce operational costs. Some of the biggest benefits to medicine have recently come from the Surgical Sutures sector. Major players in the Surgical Sutures market, including Covidien, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, Smith & Nephew, Integra Lifesciences, Peter Surgical, Internacional farmaceutica, CONMED CORPORATION, and Sutures India Pvt. Ltd., are attempting to increase market demand by investing in research and development operations.
Ethicon U.S. LLC (Ethicon), a part of Johnson & Johnson, produces medical equipment under the names Ethicon Inc. and Ethicon Endo-Surgery Inc. It manufactures and markets surgical tools and devices. The company's primary products include staplers, energy devices, clip appliers, trocars, hemostats, endocutters, suturing devices, endoscopic instruments, electrosurgical and irrigation products, meshes, and allografts. Its products are used to treat obesity, colorectal, thoracic, and hernia conditions as well as cancer in both open and minimally invasive procedures. Ethicon also offers sophisticated bipolar energy devices and ultrasonic energy devices. The company has locations in the Americas, Europe, and Asia-Pacific for manufacture, sales, and surgical education. Ethicon is based in Cincinnati, Ohio, a city in the United States. The ProxiSureTM Suturing Device will be available in the United States starting in August 2021, according to Ethicon US, LLC.
The primary business activities of Smith & Nephew Plc (Smith & Nephew) include the development, manufacture, and marketing of medical devices for use in orthopaedic repair and trauma, sports medicine, ENT, and advanced wound therapy. The company offers robotics-assisted technologies, knee and hip implants to replace diseased, worn-out, or injured joints, trauma-related products to support fractures, and operations to correct deformities. It also offers equipment and supplies for removing and mending soft tissue in addition to products for healing wounds. Smith & Nephew sells its products to a variety of audiences, including doctors, general practitioners, surgeons, nurses, and buying staff at hospitals. It also sells its products to health insurers. The business sells its products across North America, Europe, Asia-Pacific, Africa, and the Middle East. The Smith & Nephew corporate office is located in Watford, Hertfordshire, the United Kingdom. In September 2020, Smith & Nephew (UK) unveiled the NOVOSTITCH PRO Meniscal Repair System, an automated suturing tool.
· Covidien
· Ethicon US, LLC. (Johnson & Johnson Services, Inc.)
· B. Braun Melsungen AG
· Smith & Nephew
· Integra Lifesciences
· Peter Surgical
· Internacional farmaceutica
· CONMED CORPORATION
· Sutures India Pvt. Ltd.
April 2021: The "TEFLENE" brand of non-absorbable polytetrafluoroethylene sutures was introduced by Dolphin Sutures Company. It is a non-absorbable, extremely smooth polytetrafluoroethylene (PTFE) monofilament suture. The company also mentioned the expansion of its product line in India.
In March 2021: Origami Surgical Inc. has been given permission by the US Food and Drug Administration (FDA) to commercialize three novel devices utilizing its cutting-edge StitchKit robotic platform technology.
September 2019: Working together were Smith & Nephew (UK) and VirtaMed AG (Switzerland). In order to give surgical simulation training, the companies collaborated. This was done as part of their portfolio of training and education for cutting-edge surgical devices
· Absorbable
· Non Absorbable
· Monofilament
· Multifilament
· Ophthalmic Surgery
· Cardiovascular Surgery
· Orthopedic Surgery
· Neurological Surgery
· Others
· North America
- US
- Canada
· Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
· Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
· Rest of the World
- Middle East
- Africa
- Latin America
|
Report Attribute/Metric |
Details |
|
Market Size 2022 |
USD 3.7 Billion |
|
Market Size 2023 |
USD 4.2 Billion |
|
Market Size 2032 |
USD 6.3 Billion |
|
Compound Annual Growth Rate (CAGR) |
5.20% (2023-2032) |
|
Base Year |
2022 |
|
Market Forecast Period |
2023-2032 |
|
Historical Data |
2018- 2022 |
|
Market Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Type, Filament, Application, and Region |
|
Geographies Covered |
North America, Europe, Asia Pacific, and the Rest of the World |
|
Countries Covered |
The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
|
Key Companies Profiled |
Covidien, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, Smith & Nephew, Integra Lifesciences, Peter Surgical, Internacional farmaceutica, CONMED CORPORATION, and Sutures India Pvt. Ltd. |
|
Key Market Opportunities |
Technological advancements in suture design |
|
Key Market Dynamics |
The rise in the hospital admission of chronic disease patients, favorable reimbursement scenario, and increased trauma cases |
The global Surgical Sutures Market was valued at USD 3.7 billion in 2022, and it is estimated to reach USD 6.3 billion by 2032.
The global market is projected to grow at a CAGR of 5.20% during the forecast period, 2023-2032
North America had the largest share in the global market
The key players in the market are Covidien, Ethicon US, LLC. (Johnson & Johnson Services, Inc.), B. Braun Melsungen AG, Smith & Nephew, Integra Lifesciences, Peter Surgical, Internacional farmaceutica, CONMED CORPORATION, and Sutures India Pvt. Ltd.
The Absorbable Type dominated the market in 2022.
The Multifilament Filament had the largest share in the global market.
Report Code :
RL6585
Published on :
Aug 2023
Request a Free Sample Report
Speak to Analyst